OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues
Tyng‐Yuan Jang, Yu‐Ju Wei, Ta-Wei Liu, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Tyng‐Yuan Jang, Yu‐Ju Wei, Ta-Wei Liu, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
EASL Clinical Practice Guidelines on hepatitis delta virus
Maurizia Rossana Brunetto, G. Ricco, Francesco Negro, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 433-460
Open Access | Times Cited: 129
Maurizia Rossana Brunetto, G. Ricco, Francesco Negro, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 433-460
Open Access | Times Cited: 129
Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?
Francesco Paolo Russo, Alberto Zanetto, Elisa Pinto, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 500-500
Open Access | Times Cited: 56
Francesco Paolo Russo, Alberto Zanetto, Elisa Pinto, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 500-500
Open Access | Times Cited: 56
Association of hepatitis delta virus with liver morbidity and mortality: A systematic literature review and meta-analysis
Robert G. Gish, Robert J. Wong, Gian Luca Di Tanna, et al.
Hepatology (2023) Vol. 79, Iss. 5, pp. 1129-1140
Open Access | Times Cited: 23
Robert G. Gish, Robert J. Wong, Gian Luca Di Tanna, et al.
Hepatology (2023) Vol. 79, Iss. 5, pp. 1129-1140
Open Access | Times Cited: 23
Hepatitis Delta Virus and Hepatocellular Carcinoma
Daniele Lombardo, Maria Stella Franzè, Giuseppe Caminiti, et al.
Pathogens (2024) Vol. 13, Iss. 5, pp. 362-362
Open Access | Times Cited: 8
Daniele Lombardo, Maria Stella Franzè, Giuseppe Caminiti, et al.
Pathogens (2024) Vol. 13, Iss. 5, pp. 362-362
Open Access | Times Cited: 8
Review of Related Factors for Persistent Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma
Nevin Varghese, Amry Majeed, Suraj Nyalakonda, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 777-777
Open Access | Times Cited: 7
Nevin Varghese, Amry Majeed, Suraj Nyalakonda, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 777-777
Open Access | Times Cited: 7
Air pollution as a potential a risk factor for hepatocellular carcinoma in Taiwanese patients after adjusting for chronic viral hepatitis
Tyng‐Yuan Jang, Chi-Chang Ho, Chih‐Da Wu, et al.
Journal of the Chinese Medical Association (2024) Vol. 87, Iss. 3, pp. 287-291
Open Access | Times Cited: 5
Tyng‐Yuan Jang, Chi-Chang Ho, Chih‐Da Wu, et al.
Journal of the Chinese Medical Association (2024) Vol. 87, Iss. 3, pp. 287-291
Open Access | Times Cited: 5
Air Pollution Associated With Mortality Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues
Tyng‐Yuan Jang, Yuting Zeng, Po‐Cheng Liang, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access
Tyng‐Yuan Jang, Yuting Zeng, Po‐Cheng Liang, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access
Decreased incidence of hepatocellular carcinoma in non‐cirrhotic and low‐viral‐load chronic hepatitis B patients treated with nucleotide/nucleoside analogs
Tyng‐Yuan Jang, Chia‐Yen Dai
Advances in digestive medicine (2025)
Closed Access
Tyng‐Yuan Jang, Chia‐Yen Dai
Advances in digestive medicine (2025)
Closed Access
Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada
Carla Osiowy, Ken Swidinsky, Sarah Haylock‐Jacobs, et al.
JHEP Reports (2022) Vol. 4, Iss. 5, pp. 100461-100461
Open Access | Times Cited: 17
Carla Osiowy, Ken Swidinsky, Sarah Haylock‐Jacobs, et al.
JHEP Reports (2022) Vol. 4, Iss. 5, pp. 100461-100461
Open Access | Times Cited: 17
Hepatitis D virus: Improving virological knowledge to develop new treatments
Pierre Khalfi, Patrick T. Kennedy, Karim Majzoub, et al.
Antiviral Research (2022) Vol. 209, pp. 105461-105461
Open Access | Times Cited: 16
Pierre Khalfi, Patrick T. Kennedy, Karim Majzoub, et al.
Antiviral Research (2022) Vol. 209, pp. 105461-105461
Open Access | Times Cited: 16
Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection
Federico Costante, Leonardo Stella, Francesco Santopaolo, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 713-724
Open Access | Times Cited: 10
Federico Costante, Leonardo Stella, Francesco Santopaolo, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 713-724
Open Access | Times Cited: 10
Beyond the Usual Suspects: Hepatitis E Virus and Its Implications in Hepatocellular Carcinoma
Mara Klöhn, Jil Alexandra Schrader, Yannick Brüggemann, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5867-5867
Open Access | Times Cited: 18
Mara Klöhn, Jil Alexandra Schrader, Yannick Brüggemann, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5867-5867
Open Access | Times Cited: 18
Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma
Edoardo G. Giannini, Andrea Pasta, Giulia Pieri, et al.
Liver International (2024) Vol. 44, Iss. 7, pp. 1588-1599
Open Access | Times Cited: 2
Edoardo G. Giannini, Andrea Pasta, Giulia Pieri, et al.
Liver International (2024) Vol. 44, Iss. 7, pp. 1588-1599
Open Access | Times Cited: 2
Role of Air Pollution in Development of Hepatocellular Carcinoma Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues
Tyng‐Yuan Jang, Yong Zeng, Po‐Cheng Liang, et al.
Liver International (2024)
Closed Access | Times Cited: 2
Tyng‐Yuan Jang, Yong Zeng, Po‐Cheng Liang, et al.
Liver International (2024)
Closed Access | Times Cited: 2
On‐treatment gamma‐glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients
Chung‐Feng Huang, Tyng‐Yuan Jang, Dae Won Jun, et al.
Liver International (2021) Vol. 42, Iss. 1, pp. 59-68
Closed Access | Times Cited: 15
Chung‐Feng Huang, Tyng‐Yuan Jang, Dae Won Jun, et al.
Liver International (2021) Vol. 42, Iss. 1, pp. 59-68
Closed Access | Times Cited: 15
Hepatitis E virus infection and risk of hepatocellular carcinoma: A systematic review and meta-analysis
Xia Yin, Fanggong Kan
Cancer Epidemiology (2023) Vol. 87, pp. 102457-102457
Closed Access | Times Cited: 5
Xia Yin, Fanggong Kan
Cancer Epidemiology (2023) Vol. 87, pp. 102457-102457
Closed Access | Times Cited: 5
Progression of liver disease and associated risk of hepatocellular carcinoma
Edoardo Poli, Eléonora De Martin
Hepatoma Research (2024)
Open Access | Times Cited: 1
Edoardo Poli, Eléonora De Martin
Hepatoma Research (2024)
Open Access | Times Cited: 1
The Changing Face of Hepatitis Delta Virus Associated Hepatocellular Carcinoma
Mariana Cardoso, Mariana Verdelho Machado
Cancers (2024) Vol. 16, Iss. 22, pp. 3723-3723
Open Access | Times Cited: 1
Mariana Cardoso, Mariana Verdelho Machado
Cancers (2024) Vol. 16, Iss. 22, pp. 3723-3723
Open Access | Times Cited: 1
Hepatitis Delta: Current Knowledge and Future Directions.
Marcia Lange, Dina Zaret, Tatyana Kushner
PubMed (2022) Vol. 18, Iss. 9, pp. 508-520
Closed Access | Times Cited: 7
Marcia Lange, Dina Zaret, Tatyana Kushner
PubMed (2022) Vol. 18, Iss. 9, pp. 508-520
Closed Access | Times Cited: 7
Hepatitis delta virus: Disease assessment and stratification
Apostolos Koffas, Lung‐Yi Mak, Patrick Kennedy
Journal of Viral Hepatitis (2022) Vol. 30, Iss. S1, pp. 12-21
Open Access | Times Cited: 7
Apostolos Koffas, Lung‐Yi Mak, Patrick Kennedy
Journal of Viral Hepatitis (2022) Vol. 30, Iss. S1, pp. 12-21
Open Access | Times Cited: 7
Five‐year follow‐up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D
Olympia E. Anastasiou, Florin Alexandru Căruntu, Manuela Curescu, et al.
Liver International (2023) Vol. 44, Iss. 1, pp. 139-147
Open Access | Times Cited: 3
Olympia E. Anastasiou, Florin Alexandru Căruntu, Manuela Curescu, et al.
Liver International (2023) Vol. 44, Iss. 1, pp. 139-147
Open Access | Times Cited: 3
Hepatitis B surface antigen loss in chronic hepatitis B patients with low‐viral‐load
Tyng‐Yuan Jang, Batbold Batsaikhan, Yo‐Chia Chen, et al.
Journal of Gastroenterology and Hepatology (2024)
Closed Access
Tyng‐Yuan Jang, Batbold Batsaikhan, Yo‐Chia Chen, et al.
Journal of Gastroenterology and Hepatology (2024)
Closed Access
Acute Hepatitis B Infection: U.S. Policy and Guidelines
Sally Henin, Jeffrey Gruenglas, Miranda Anaya, et al.
IntechOpen eBooks (2024)
Open Access
Sally Henin, Jeffrey Gruenglas, Miranda Anaya, et al.
IntechOpen eBooks (2024)
Open Access
Epidemiological, diagnostic, therapeutic and prognostic impact of hepatitis B and D virus infection on hepatocellular carcinoma: a review of the literature
Angelo Bruni, Chiara Castellana, Elton Dajti, et al.
Virology (2024) Vol. 600, pp. 110273-110273
Open Access
Angelo Bruni, Chiara Castellana, Elton Dajti, et al.
Virology (2024) Vol. 600, pp. 110273-110273
Open Access
Multisociety consensus recommendations on hepatitis delta virus infection
Saleh A. Alqahtani, Faisal M. Sanai, Mohammed A. Banama, et al.
Saudi Journal of Gastroenterology (2024) Vol. 31, Iss. 1, pp. 5-13
Open Access
Saleh A. Alqahtani, Faisal M. Sanai, Mohammed A. Banama, et al.
Saudi Journal of Gastroenterology (2024) Vol. 31, Iss. 1, pp. 5-13
Open Access
